Brief: Trisalus Life Sciences Inc- Full Year 2024 Sales Growth Expected To Exceed 50%
March 11 (Reuters) - TriSalus Life Sciences Inc
TLSI.O :
* TRISALUS LIFE SCIENCES INC- FULL YEAR 2024 SALES GROWTH
EXPECTED
TO EXCEED 50%
* TRISALUS LIFE SCIENCES INC - SEES Q4 OF 2023 REVENUE
APPROXIMATELY $5.7 MILLION
* TRISALUS LIFE SCIENCES INC - SEES FULL YEAR 2023 REVENUE
OF
APPROXIMATELY $18.5 MILLION
* TRISALUS LIFE SCIENCES INC - SEES CASH AND CASH
EQUIVALENTS
BALANCES OF APPROXIMATELY $11.8 MILLION AS OF DECEMBER 31, 2023
Source text for Eikon: ID:nBw4gv9zNa
Further company coverage: TLSI.O
Recent news on TriSalus Life Sciences
See all newsTriSalus jumps after FDA clears liver treatment device
Brief: Trisalus Life Sciences Receives FDA Clearance For Trinav Advance
TriSalus Life Sciences Inc reports results for the quarter ended June 30 - Earnings Summary
TriSalus Life Sciences Q2 revenue beats estimates
TriSalus Life Sciences Inc expected to post a loss of 15 cents a share - Earnings Preview